Treatment success rate for patients treated for MDR-TB in Central African Republic

Central African Republic: Treatment success rate for patients treated for MDR-TB was 69.0% in 2021. ▼ Falling

Latest (2021)
69.0%
Change on year
down 13.8%
World rank
101st
of 163 countries
All-time high
88.0%
in 2015
All-time low
59.0%
in 2016
Years of data
10
2012–2021

Treatment success rate for patients treated for MDR-TB in Central African Republic, 2012–2021

0204060802012201620212012: 812013: 812014: 762015: 882016: 592017: 802018: 732019: 622020: 802021: 69

Source: World Health Organization, Global Health Observatory.

Analysis

In 2021, treatment success rate for patients treated for mdr-tb in Central African Republic stood at 69.0%.

That represents a change of down 13.8% on the previous year and down 14.8% over ten years.

Over the whole period, treatment success rate for patients treated for mdr-tb in Central African Republic peaked at 88.0% in 2015 and was at its lowest, 59.0%, in 2016.

Central African Republic ranks 101st of 163 countries on this measure, in the middle of the range.

Treatment success rate for patients treated for MDR-TB in Central African Republic, year by year

Annual values for Treatment success rate for patients treated for MDR-TB (%) in Central African Republic, 2012 to 2021.
Year Value Change
2012 81.0%
2013 81.0% +0.0%
2014 76.0% -6.2%
2015 88.0% +15.8%
2016 59.0% -33.0%
2017 80.0% +35.6%
2018 73.0% -8.8%
2019 62.0% -15.1%
2020 80.0% +29.0%
2021 69.0% -13.8%

Averages by decade

DecadeAverage LowestHighest Years
2010s 75.0% 59.0% 88.0% 8
2020s 74.5% 69.0% 80.0% 2

Countries ranked near Central African Republic

  1. 101 Burkina Faso 69.0% compare
  2. 101 Zimbabwe 69.0% compare
  3. 104 Armenia 68.0% compare
  4. 104 China 68.0% compare

See the full ranking of 175 places →

More health data for Central African Republic

All data for Central African Republic →

Frequently asked questions

What is treatment success rate for patients treated for mdr-tb in Central African Republic?
Treatment success rate for patients treated for mdr-tb in Central African Republic was 69.0% in 2021, according to World Health Organization, Global Health Observatory.
What is the highest treatment success rate for patients treated for mdr-tb recorded in Central African Republic?
The highest recorded value was 88.0% in 2015.
What is the lowest treatment success rate for patients treated for mdr-tb recorded in Central African Republic?
The lowest recorded value was 59.0% in 2016.
How does Central African Republic rank for treatment success rate for patients treated for mdr-tb?
Central African Republic ranks 101st out of 163 countries with data for 2021.
Is treatment success rate for patients treated for mdr-tb rising or falling in Central African Republic?
Over the last ten years it is down 14.8%. The long-run trend across the full record is falling.
Where does this Central African Republic data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Treatment success rate for patients treated for MDR-TB in Central African Republic. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 11 September 2026, from https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/central-african-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/central-african-republic/">Treatment success rate for patients treated for MDR-TB in Central African Republic</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed